| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 78815 |
Positron emission tomography (PET) for limited area imaging |
1,350 |
1,142 |
$640K |
| 77014 |
|
4,735 |
716 |
$183K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
3,154 |
1,349 |
$146K |
| 99215 |
Prolong outpt/office vis |
3,573 |
2,702 |
$116K |
| 77300 |
|
584 |
278 |
$98K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,470 |
2,860 |
$91K |
| 77427 |
|
1,513 |
607 |
$78K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
17,855 |
10,117 |
$70K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
5,539 |
2,635 |
$62K |
| 77334 |
|
601 |
420 |
$60K |
| 77336 |
|
1,516 |
605 |
$55K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
3,286 |
1,455 |
$42K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
5,351 |
3,553 |
$39K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,397 |
1,044 |
$35K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
1,452 |
1,237 |
$31K |
| J0897 |
Injection, denosumab, 1 mg |
27 |
12 |
$17K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
796 |
682 |
$17K |
| 99205 |
Prolong outpt/office vis |
252 |
194 |
$14K |
| 36415 |
Collection of venous blood by venipuncture |
14,532 |
9,915 |
$13K |
| 77263 |
|
223 |
174 |
$13K |
| 77280 |
|
254 |
172 |
$12K |
| 96523 |
|
839 |
620 |
$8K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,148 |
595 |
$6K |
| 96367 |
|
393 |
162 |
$6K |
| 77387 |
|
95 |
12 |
$6K |
| 77290 |
|
57 |
39 |
$4K |
| G6015 |
Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session |
186 |
12 |
$4K |
| 77417 |
|
605 |
284 |
$4K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,635 |
1,113 |
$3K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
216 |
92 |
$2K |
| 96417 |
|
24 |
14 |
$1K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,382 |
503 |
$1K |
| 96415 |
|
28 |
12 |
$830.42 |
| 96368 |
|
81 |
38 |
$596.68 |
| 77331 |
|
33 |
16 |
$370.62 |
| G6002 |
Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy |
156 |
13 |
$238.90 |
| G6012 |
Radiation treatment delivery, 3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev |
96 |
12 |
$168.08 |
| 36591 |
|
1,253 |
685 |
$157.73 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
89 |
38 |
$58.92 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
205 |
178 |
$20.73 |
| 99070 |
|
35 |
12 |
$0.00 |